Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome

10 Feb 2012

Abstract excerpt

Glioblastomas (GBMs) containing foci that resemble oligodendroglioma are deﬁned as GBM with oligodendroglioma component (GBMO). However, whether GBMO is a distinct clinicopathological variant of GBM or merely represents a divergent pattern of differentiation remains controversial. We investigated 219 consecutive primary GBMs, of which 40 (18.3%) were confirmed as GBMOs. The clinical features and genetic proﬁles...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Chromatin Remodeling and Cancer
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22326863
DOI: 10.1093/neuonc/nor232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcomePMID 22326863Read ↗

Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.Semantic proximity Read ↗

Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Semantic proximity Read ↗

Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.Semantic proximity Read ↗

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.Semantic proximity Read ↗

Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.Semantic proximity Read ↗

Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.Semantic proximity Read ↗

Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.Semantic proximity Read ↗

Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic SubclassificationSemantic proximity Read ↗

Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular StudySemantic proximity Read ↗

Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.Semantic proximity Read ↗

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsSemantic proximity Read ↗

Glioblastoma: Biology, Genetics, and BehaviorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.